Webinar: Legal guidance on bringing DTx to Germany & France with CMS

Scaling digital therapeutics (DTx) internationally is a challenge. The legal framework for DTx is complex. Companies wishing to successfully place a DTx on a given market, promote it there and get paid for it need to take into account several legal requirements. And once a company has launched a DTx in one market, similar questions occur when planning the expansion to further markets. Germany – with the apps on prescription (DiGA) – and France – with the PECAN – are frontrunners when it comes to the integration of DTx into healthcare systems.

In this webinar we explain the respective legal framework, provide practical guidance on typical challenges and thereby help companies wishing to enter these markets avoid typical pitfalls.

Speakers are specialized lawyers from Germany and France of the international lawfirm CMS:

Dr Roland Wiring: Dr. Roland Wiring - Intellectual Property Partner in Hamburg (cms.law)

Jean-Baptiste Thiénot: Jean-Baptiste Thiénot | Lawyer | Intellectual property (cms.law)

Myriam El Andaloussi: Myriam El Andaloussi | Lawyer | Technology & Media | Paris (cms.law)